As the ovarian tumour cells are known to excrete the endothelial growth factor VEGF-A as well, this suggests an autocrine/paracrine growth factor function of VEGF-A in ovarian cancer through the AKT/mTOR signalling pathway. This evidence concerns the gene AKT1 and ovarian cancer.